Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,266 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials.
Park R, Lopes da Silva L, Nissaisorakarn V, Riano I, Williamson S, Sun W, Saeed A. Park R, et al. Among authors: williamson s. J Hepatocell Carcinoma. 2021 Mar 22;8:145-154. doi: 10.2147/JHC.S268305. eCollection 2021. J Hepatocell Carcinoma. 2021. PMID: 33791250 Free PMC article. Review.
Programmed Cell Death-Ligand 1 (PD-L1) Expression in Anal Cancer.
Govindarajan R, Gujja S, Siegel ER, Batra A, Saeed A, Lai K, James JD, Fogel BJ, Williamson S. Govindarajan R, et al. Among authors: williamson s. Am J Clin Oncol. 2018 Jul;41(7):638-642. doi: 10.1097/COC.0000000000000343. Am J Clin Oncol. 2018. PMID: 27849650
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.
Saeed A, Park R, Dai J, Al-Rajabi R, Kasi A, Baranda J, Williamson S, Saeed A, Ripp J, Collins Z, Mulvaney K, Shugrue M, Firth-Braun J, Godwin AK, Madan R, Phadnis M, Sun W. Saeed A, et al. Among authors: williamson s. Cell Rep Med. 2023 Feb 21;4(2):100916. doi: 10.1016/j.xcrm.2023.100916. Epub 2023 Jan 25. Cell Rep Med. 2023. PMID: 36702123 Free PMC article. Clinical Trial.
A phase II study of perioperative pembrolizumab plus mFOLFOX in patients with potentially resectable esophagus, gastroesophageal junction (GEJ), and stomach adenocarcinoma.
Sun W, Veeramachaneni N, Al-Rajabi R, Madan R, Kasi A, Al-Kasspooles M, Baranda J, Saeed A, Phadnis MA, Godwin AK, Olyaee M, Streeter N, Nagji A, Dai J, Williamson S. Sun W, et al. Among authors: williamson s. Cancer Med. 2023 Aug;12(15):16098-16107. doi: 10.1002/cam4.6263. Epub 2023 Jun 16. Cancer Med. 2023. PMID: 37326317 Free PMC article. Clinical Trial.
Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort.
Saeed A, Park R, Pathak H, Al-Bzour AN, Dai J, Phadnis M, Al-Rajabi R, Kasi A, Baranda J, Sun W, Williamson S, Chiu YC, Osmanbeyoglu HU, Madan R, Abushukair H, Mulvaney K, Godwin AK, Saeed A. Saeed A, et al. Among authors: williamson s. Nat Commun. 2024 Feb 20;15(1):1533. doi: 10.1038/s41467-024-45960-2. Nat Commun. 2024. PMID: 38378868 Free PMC article. Clinical Trial.
Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.
Khan QJ, Bivona CR, Martin GA, Zhang J, Liu B, He J, Li KH, Nelson M, Williamson S, Doolittle GC, Sun W, Mudaranthakam DP, Streeter NR, McGuirk JP, Al-Rajabi R, Hoffmann M, Kasi A, Parikh RA, Zhong C, Mitchell L, Pessetto ZY, Pathak H, Ghosh A, LaFaver S, Sharma P, Godwin AK. Khan QJ, et al. Among authors: williamson s. JAMA Oncol. 2022 Jul 1;8(7):1053-1058. doi: 10.1001/jamaoncol.2022.0752. JAMA Oncol. 2022. PMID: 35446353 Free PMC article.
1,266 results